Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery

This clinical study assesses the efficacy of two novel bioactive solutions, Theravex Oral and Theravex Tissue Care Plus, in enhancing soft tissue healing after periodontal surgery. The study focuses on patients undergoing a Modified Free Gingival Graft (M-FGG) technique to treat gingival recessions around mandibular incisors. Participants are randomly assigned to a test group receiving the Theravex treatment or a control group receiving a saline placebo. The primary goal is to measure the impact of these solutions on root coverage and other key outcomes, such as tissue gain, color integration, and postoperative pain, over a one-year period.

NCT Number	NCT07430670
Lead Sponsor	Universidad Complutense de Madrid Collaborators: Biointelligent Technology Systems SL
Conditions	Gingival Recession, Localized
Enrollment	30 participants
Start Date	2026-02-17
Primary Completion	2027-07-06 (estimated)
Study Completion	2027-07-06 (estimated)
Updated on ClinicalTrials.gov	2026-02-24